Merck stock hits 52-week high as vaccine policy shift and JPM conference loom
New York, Jan 6, 2026, 14:16 EST — Regular session Merck & Co shares rose about 1.1% to $108.60 in afternoon trading on Tuesday and earlier hit a 52-week high of $110.16. The broader S&P 500 and the Health Care Select Sector SPDR Fund were also higher. The stock has drawn fresh attention after Merck said CEO Robert M. Davis and Merck Research Laboratories chief Dean Y. Li will take part in a fireside chat at the J.P. Morgan Healthcare Conference on Jan. 12. The annual gathering is a key early-year venue for drugmakers to frame pipeline priorities and set